...
首页> 外文期刊>Epigenetics: official journal of the DNA Methylation Society >A comparison of existing global DNA methylation assays to low-coverage whole-genome bisulfite sequencing for epidemiological studies
【24h】

A comparison of existing global DNA methylation assays to low-coverage whole-genome bisulfite sequencing for epidemiological studies

机译:流行病学研究中存在全局DNA甲基化测定对低覆盖全基因组亚硫酸氢盐测序的比较

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

DNA methylation is an epigenetic mark at the interface of genetic and environmental factors relevant to human disease. Quantitative assessments of global DNA methylation levels have therefore become important tools in epidemiology research, particularly for understanding effects of environmental exposures in complex diseases. Among the available methods of quantitative DNA methylation measurements, bisulfite sequencing is considered the gold standard, but whole-genome bisulfite sequencing (WGBS) has previously been considered too costly for epidemiology studies with high sample numbers. Pyrosequencing of repetitive sequences within bisulfite-treated DNA has been routinely used as a surrogate for global DNA methylation, but a comparison of pyrosequencing to WGBS for accuracy and reproducibility of methylation levels has not been performed. This study compared the global methylation levels measured from uniquely mappable (non-repetitive) WGBS sequences to pyrosequencing assays of several repeat sequences and repeat assay-matched WGBS data and determined uniquely mappable WGBS data to be the most reproducible and accurate measurement of global DNA methylation levels. We determined sources of variation in repetitive pyrosequencing assays to be PCR amplification bias, PCR primer selection bias in methylation levels of targeted sequences, and inherent variability in methylation levels of repeat sequences. Low-coverage, uniquely mappable WGBS showed the strongest correlation between replicates of all assays. By using multiplexing by indexed bar codes, the cost of WGBS can be lowered significantly to improve the accuracy of global DNA methylation assessments for human studies.
机译:DNA甲基化是与人类疾病相关的遗传和环境因素界面的表观遗传标记。因此,全局DNA甲基化水平的定量评估成为流行病学研究的重要工具,特别是为了了解在复杂疾病中的环境暴露的影响。在可用的定量DNA甲基化测量方法中,亚硫酸氢盐测序被认为是金标准,但全基因组亚硫酸氢盐测序(WGBs)先前已被认为是具有高样品数的流行病学研究的昂贵。二硫酸氢盐处理的DNA中的重复序列的焦点已经常规用作全球DNA甲基化的替代物,但毫龋上对WGB的比较尚未进行甲基化水平的准确性和再现性。该研究将从唯一可用的(非重复性)WGBS序列测量的全球甲基化水平与几种重复序列的焦肌序列测定,并重复测定匹配的WGBS数据,并确定唯一可映射的WGBS数据,以成为全球DNA甲基化的最可重复和准确的测量水平。我们确定重复辐射测定测定的变异来源,以PCR扩增偏压,靶向序列的甲基化水平中的PCR引物选择偏压,以及重复序列的甲基化水平的固有变异性。低覆盖,唯一可映射的WGB表示所有测定复制之间的最强相关性。通过使用索引条形码使用多路复用,可以显着降低WGB的成本,以提高全球DNA甲基化评估对人类研究的准确性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号